Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity

Glioblastoma (GBM) is poorly responsive to therapy and invariably lethal. One conceivable strategy to circumvent this intractability is to co-target distinctive mechanistic components of the disease, aiming to concomitantly disrupt multiple capabilities required for tumor progression and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chryplewicz, Agnieszka, Scotton, Julie, Tichet, Mélanie, Zomer, Anoek, Shchors, Ksenya, Joyce, Johanna A., Homicsko, Krisztian, Hanahan, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580613/
https://www.ncbi.nlm.nih.gov/pubmed/36113478
http://dx.doi.org/10.1016/j.ccell.2022.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580613/
https://www.ncbi.nlm.nih.gov/pubmed/36113478
http://dx.doi.org/10.1016/j.ccell.2022.08.014

Ejemplares similares